Liver International
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
Table of contents
- 1149
-
Issue Information| 2023
- 1154
-
Carvedilol, probably the β‐blocker of choice for everyone with cirrhosis and portal hypertension: But not so fast!Villanueva, Càndid / Tripathi, Dhiraj et al. | 2023
- 1157
-
Future anti‐HDV treatment strategies, including those aimed at HBV functional cureTan, Yong Chuan / Lee, Guan Huei / Huang, Daniel Q. et al. | 2023
- 1170
-
Hepatocytic ballooning in non‐alcoholic steatohepatitis: Dilemmas and future directionsLi, Yang‐Yang / Zheng, Tian‐Lei / Xiao, Shu‐Yuan et al. | 2023
- 1183
-
Carvedilol as the new non‐selective beta‐blocker of choice in patients with cirrhosis and portal hypertensionTurco, Laura / Reiberger, Thomas / Vitale, Giovanni et al. | 2023
- 1195
-
Global treatment rate and barriers to direct‐acting antiviral therapy: A systematic review and meta‐analysis of 146 studies and 1 760 352 hepatitis C virus patientsNguyen, Vy H. / Huang, Daniel Q. / Le, Michael H. et al. | 2023
- 1204
-
Low risk of viral hepatitis amongst patients with severe mental disordersFernández, Tábatha / Plana, Teresa / Tardón, Laia et al. | 2023
- 1213
-
Toll‐like receptor 7 agonist, GS‐986, is an immune‐stimulant inducing follicular helper T cells and expanding HBs antigen‐specific B cells in vitroMori, Taizo / Yoshio, Sachiyo / Yoshikawa, Shiori et al. | 2023
- 1225
-
Hepatitis C screening and detection program in a large population: Epidemiological transition and characterization of the diseaseKershenobich, David / Higuera‐de‐la Tijera, Fatima / Flores, Nayelli et al. | 2023
- 1234
-
Novel urinary protein panels for the non‐invasive diagnosis of non‐alcoholic fatty liver disease and fibrosis stagesFeng, Gong / Zhang, Xiaoxun / Zhang, Liangjun et al. | 2023
- 1247
-
Fatty liver disease, heart rate and cardiac remodelling: Evidence from the UK BiobankJamialahmadi, Oveis / Tavaglione, Federica / Rawshani, Araz et al. | 2023
- 1256
-
Subclinical liver traits are associated with structural and hemodynamic brain imaging markersYilmaz, Pinar / Alferink, Louise J. M. / Cremers, Lotte G. M. et al. | 2023
- 1269
-
Right and left liver lobe biopsies by minilaparoscopy reveal clinically significant sampling error in staging and grading of autoimmune hepatitisJohannes, Hartl / Malte, Wehmeyer / Shaima, Alali et al. | 2023
- 1277
-
Risk factors for more rapid progression of severe liver fibrosis in children with cystic fibrosis‐related liver disease: A multi‐center study validated by liver biopsySakhuja, Shruti / Staples, Heather M. / Minard, Charles G. et al. | 2023
- 1287
-
Behavioural activity pattern, genetic factors, and the risk of nonalcoholic fatty liver disease: A prospective study in the UK BiobankGe, Xinyuan / Wang, Xiao / Yan, Yuqian et al. | 2023
- 1298
-
Combination of GM CSF and carbapenem is superior to carbapenem monotherapy in difficult‐to‐treat spontaneous bacterial peritonitis: A randomized controlled trialPrakash, Vikash / Arora, Vinod / Jindal, Ankur et al. | 2023
- 1307
-
Spermidine suppresses the activation of hepatic stellate cells to cure liver fibrosis through autophagy activator MAP1SShi, Boyun / Wang, Wei / Ye, Mengting et al. | 2023
- 1320
-
Association between antihypertensive drugs and hepatocellular carcinoma: A trans‐ancestry and drug‐target Mendelian randomization studyWang, Zhenqian / Lu, Jiawen / Hu, Jingyi et al. | 2023
- 1332
-
Steatotic hepatocellular carcinoma: Association of MRI findings to underlying liver disease and clinicopathological characteristicsPark, Jae Hyon / Park, Young Nyun / Kim, Myeong‐Jin et al. | 2023
- 1345
-
Transcriptomics confirm the establishment of a liver‐immune dual‐humanized mouse model after transplantation of a single type of human bone marrow mesenchymal stem cellSun, Suwan / Yang, Hui / Xin, Jiaojiao et al. | 2023
- 1357
-
Non‐tuberculous mycobacteriosis of the liver responsive to empiric therapySiciliani, Luisa / Vanoli, Alessandro / Berton, Francesca et al. | 2023
- 1360
-
Fatty liver disease at the basis of cardiac remodelling and increased heart rate: Insights from the UK BiobankBoeckmans, Joost / Schattenberg, Jörn M. et al. | 2023
- 1362
-
Reply to: “Fatty liver disease at the basis of cardiac remodelling and increased heart rate: Insights from the UK Biobank”Tavaglione, Federica / Jamialahmadi, Oveis / Ljungman, Charlotta et al. | 2023
- 1365
-
Overcoming the challenges of eliminating viral hepatitis in low‐ and middle‐income countriesVyas, Ashish Kumar et al. | 2023